NASDAQ
Protagenic Therapeutics, Inc. (PTIX) has a free cash flow growth of 72.54% as of Friday, May 29, 2026. This represents a 170.91% increase compared to its 12-month average of -102.29%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.